Trials / Active Not Recruiting
Active Not RecruitingNCT05957276
Global Patient Registry of Inherited Retinal Diseases
Global Patient Registry of Inherited Retinal Disease
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 889 (actual)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to better understand the natural history of Inherited Retinal Disease (IRD) and help inform patient management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard of Care | Participants will not receive any intervention in this study. Participants will receive standard of care therapy. |
Timeline
- Start date
- 2023-08-31
- Primary completion
- 2026-07-03
- Completion
- 2026-07-03
- First posted
- 2023-07-24
- Last updated
- 2026-04-13
Locations
75 sites across 18 countries: United States, Australia, Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Israel, Italy, Japan, South Korea, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT05957276. Inclusion in this directory is not an endorsement.